The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 28, 2025 for Hima Bindu Potluri
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hima Bindu Potluri, a promoter of SMS Pharmaceuticals, has encumbered (pledged) 30,00,000 equity shares (3.54% of total share capital) on March 25, 2025, as a Non-Disposal Undertaking (NDU) in favour of Vistra ITCL (India) Limited (Debenture Trustee) for Avendus PE Investment Advisors. The shares serve as security for Non-Convertible Debentures issued by Potluri Laboratories Pvt Ltd, another promoter-group company. Post this event, her total encumbered shares stand at 1,36,20,000 (16.09% of share capital), which is roughly 91% of her individual shareholding of 1,50,08,840 shares (17.73%). The disclosed asset cover ratio is low at 0.41x (shares worth ~Rs.68.3 crore against Rs.165 crore of debentures). This is the second such encumbrance by her, the first being 1.06 crore shares pledged in November 2023 for VKT Pharma debentures.
Negative signal — the promoter has now pledged over 90% of her personal stake in SMS Pharma to raise debt for another group entity (Potluri Labs), indicating aggressive leveraging by the promoter group. The low asset cover (0.41x) means shares are encumbered well above their market value, which could be a concern if SMS Pharma's share price falls.